Quince Therapeutics Inc (QNCX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -44,370 | -38,878 | -11,149 | -31,385 | -22,491 |
| Depreciation Amortization | 15,442 | 15,948 | -606 | 4,203 | 4,605 |
| Income taxes - deferred | N/A | N/A | N/A | -248 | -248 |
| Accounts payable and accrued liabilities | -424 | 401 | 59 | -288 | -161 |
| Other Working Capital | -2,379 | -2,227 | -805 | 1,977 | 1,727 |
| Other Operating Activity | 7,379 | 7,664 | 4,148 | 7,449 | 4,354 |
| Operating Cash Flow | $-24,352 | $-17,092 | $-8,353 | $-18,292 | $-12,214 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 89,735 | N/A | N/A | N/A |
| PPE Investments | -124 | -78 | -39 | -70 | -46 |
| Net Acquisitions | N/A | N/A | N/A | -2,116 | N/A |
| Purchase Of Investment | -89,562 | -85,721 | -39,292 | -113,781 | -95,116 |
| Sale Of Investment | 100,727 | N/A | 48,245 | 111,209 | 84,514 |
| Other Investing Activity | 0 | 0 | 0 | -1,000 | -500 |
| Investing Cash Flow | $11,041 | $3,936 | $8,914 | $-5,758 | $-11,148 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -6 | -6 |
| Common Stock Issued | 225 | 225 | 190 | 149 | 92 |
| Other Financing Activity | -5,000 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $-4,775 | $225 | $190 | $143 | $86 |
| Exchange Rate Effect | 9 | 69 | 310 | 80 | 329 |
| Beginning Cash Position | 20,752 | 20,752 | 20,752 | 44,579 | 44,579 |
| End Cash Position | 2,675 | 7,890 | 21,813 | 20,752 | 21,632 |
| Net Cash Flow | $-18,077 | $-12,862 | $1,061 | $-23,827 | $-22,947 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,352 | -17,092 | -8,353 | -18,292 | -12,214 |
| Capital Expenditure | -124 | -78 | -39 | -160 | -136 |
| Free Cash Flow | -24,476 | -17,170 | -8,392 | -18,452 | -12,350 |